[When L-Dopa preparations, dopamine agonists or opioids? Therapy of restless legs syndrome].
Tings
T
T
Abteilung Klinische Neurophysiologie, Georg-August-Universität, Göttingen. ttings@med.uni-goettingen.de
Trenkwalder
C
C
D000701:Analgesics, Opioid / Q000008:administration & dosage / Q000627:therapeutic use; D018849:Controlled Clinical Trials as Topic; D003937:Diagnosis, Differential; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage / Q000627:therapeutic use; D010919:Placebos; D012148:Restless Legs Syndrome / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D013993:Tilidine / Q000008:administration & dosage / Q000627:therapeutic use; D013997:Time Factors
D000701:Analgesics, Opioid; D018491:Dopamine Agonists; D010919:Placebos; D007980:Levodopa; D013993:Tilidine
Wann L-Dopa-Präparate, Dopaminagonisten oder Opioide? Therapie des Restless-legs-Syndroms.